195 related articles for article (PubMed ID: 18650410)
1. Clinicopathologic correlation and outcome of C1q nephropathy.
Hisano S; Fukuma Y; Segawa Y; Niimi K; Kaku Y; Hatae K; Saitoh T; Takeshita M; Iwasaki H
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1637-43. PubMed ID: 18650410
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlation of C1q nephropathy in children.
Fukuma Y; Hisano S; Segawa Y; Niimi K; Tsuru N; Kaku Y; Hatae K; Kiyoshi Y; Mitsudome A; Iwasaki H
Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
[TBL] [Abstract][Full Text] [Related]
3. Pathology, clinical presentations, and outcomes of C1q nephropathy.
Vizjak A; Ferluga D; Rozic M; Hvala A; Lindic J; Levart TK; Jurcić V; Jennette JC
J Am Soc Nephrol; 2008 Nov; 19(11):2237-44. PubMed ID: 18650484
[TBL] [Abstract][Full Text] [Related]
4. C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.
Kim K; Son HE; Ryu JY; Lee H; Han SH; Ryu DR; Paik JH; Kim S; Na KY; Chae DW; Chin HJ; Oh SW
PLoS One; 2019; 14(4):e0215217. PubMed ID: 31002691
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
6. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
7. C1q nephropathy and minimal change nephrotic syndrome.
Wong CS; Fink CA; Baechle J; Harris AA; Staples AO; Brandt JR
Pediatr Nephrol; 2009 Apr; 24(4):761-7. PubMed ID: 19082635
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome.
Kanemoto K; Ito H; Anzai M; Matsumura C; Kurayama H
J Nephrol; 2013; 26(2):306-14. PubMed ID: 22641570
[TBL] [Abstract][Full Text] [Related]
9. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome?
Davenport A; Maciver AG; Mackenzie JC
Nephrol Dial Transplant; 1992; 7(5):391-6. PubMed ID: 1321373
[TBL] [Abstract][Full Text] [Related]
10. C1q nephropathy in India: a single-center study.
Kanodia KV; Vanikar AV; Patel RD; Suthar KS; Patel HV; Gumber MA; Shah PR; Trivedi HL
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):398-403. PubMed ID: 25758901
[TBL] [Abstract][Full Text] [Related]
11. IgM nephropathy in India: a single centre experience.
Vanikar AV; Kanodia KV; Patel RD; Suthar KS; Patel HV; Gumber MR; Trivedi HL
Indian J Pediatr; 2012 Aug; 79(8):1025-7. PubMed ID: 22290630
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[TBL] [Abstract][Full Text] [Related]
14. A single-center study of C1q nephropathy in children.
Roberti I; Baqi N; Vyas S; Kim DU
Pediatr Nephrol; 2009 Jan; 24(1):77-82. PubMed ID: 18688655
[TBL] [Abstract][Full Text] [Related]
15. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
Trachtman H; Laskowski J; Lee C; Renner B; Feemster A; Parikh S; Panzer SE; Zhong W; Cravedi P; Cantarelli C; Kulik L; You Z; Satchell S; Rovin B; Liu F; Kalled SL; Holers VM; Jalal D; Thurman JM
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F505-F516. PubMed ID: 34459222
[TBL] [Abstract][Full Text] [Related]
16. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
17. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
Ahmed HM; Ezzat DA; Doudar NA; Adel M
Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
[TBL] [Abstract][Full Text] [Related]
18. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
McAdams AJ; Valentini RP; Welch TR
Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
[TBL] [Abstract][Full Text] [Related]
19. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
Kadiri S; Osobamiro O; Ogunniyi J
Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.
Kazi JI; Mubarak M; Ahmed E; Akhter F; Naqvi SA; Rizvi SA
Clin Exp Nephrol; 2009 Feb; 13(1):38-43. PubMed ID: 18685922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
